Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Information on Pradaxa Lawsuits

pradaxa lawsuit informationThe popular blood thinning drug Pradaxa has now been prescribed to millions of patients with atrial fibrillation in over 70 countries to prevent blood clots. Drug maker Boehringer Ingelheim recently boasted they had earned over $1 billion from Pradaxa in one year.

Unfortunately, thousands have been injured or killed so far by uncontrollable internal bleeding while taking Pradaxa. Although the drug is still on the market, a federal judge recently ruled that those injured can file Pradaxa lawsuits for their loss.

Within 6 months of Pradaxa’s release, the FDA had received more than 500 reports of internal bleeding injury or death among patients. These included internal bleeding in the brain, intestines and kidneys, as well as heart attacks.

In December of 2011, the FDA announced a formal investigation into the safety of the drug, after reportedly receiving reports of 3,781 side effects and 542 deaths among users. This was the most of any medication in 2011.

Due to the number of Pradaxa lawsuits expected by patients, the cases have been consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. Lawyers are currently helping those affected file claims.

If you or a loved one suffered internal bleeding while taking Pradaxa, you may be entitled to substantial compensation. Contact us today to speak with a lawyer about a lawsuit against Pradaxa and whether your case qualifies.

Although all blood thinning drugs can cause internal bleeding, the maker of Pradaxa faces liability because they did not warn patients that there is no reversal agent to stop bleeding as there is with other drugs like Coumadin or Warfarin. 

In March of 2012, the Journal of Neurosurgery detailed the death of a Pradaxa patient from internal bleeding. Doctors noted that once Pradaxa causes bleeding, there is little they can do to stop it.

In September of 2012, the University of Pécs in Hungary released a study suggesting that the risks of Pradaxa may outweigh the benefits. Researchers found that those taking the drug after an acute heart condition were three times as likely to have a bleeding event.

Those filing Pradaxa lawsuits should know that they are filed individually, instead of as one class action suit. This is often more advantageous for victims. Also, lawyers will collect medical records, attend hearings and pursue your case at no cost, only receiving payment if they recover for you.

However, the federal MDL process can be a complex and highly specialized place of litigation. Before you choose a lawyer, make sure they are qualified for this type of lawsuit and have experience fighting large drug companies. The Drug Resource Center only recommends law firms that specialize in Pradaxa lawsuits.

For more information on the side effects, warnings and legal action related to the drug Pradaxa, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.

Authored by Chris Schroeder